Skandinaviska Enskilda Banken (SEB)
KURA icon

Skandinaviska Enskilda Banken (SEB)’s Kura Oncology KURA Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-53,738
Closed -$457K – 862
2024
Q4 		$457K Hold
53,738
– – ﹤0.01% 718
2024
Q3 		$1.05M Hold
53,738
– – ﹤0.01% 663
2024
Q2 		$1.11M Hold
53,738
– – 0.01% 634
2024
Q1 		$1.15M Buy
+53,738
New +$1.04M 0.01% 651

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s KURA Position: Q1 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Kura Oncology (KURA) in Q1 2025, closing a stake of 53,738 shares — an estimated $457K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in KURA in Q1 2024 and held it in 4 quarters. The position peaked at $1.15M in Q1 2024. 183 funds tracked by Wall St. Rank hold KURA as of Q1 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Kura Oncology position as of Q1 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 53,738 Kura Oncology shares in Q1 2025, an estimated $457K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Kura Oncology in Q1 2024 and held it in 4 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Kura Oncology position peaked at $1.15M in Q1 2024.
  • 183 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2025, filed 7 May 2025.